CAMBRIDGE, Mass., March 7 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation
at the Cowen and Company 27th Annual Health Care Conference will be webcast
live and may be accessed by visiting the Investors section of the Company's
website, http://www.millennium.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
Millennium management will provide an overview of the Company and
upcoming corporate events. The presentation will be delivered at 8:45 A.M.
ET on Wednesday, March 14, 2007 from The Boston Marriott Copley Place in
Boston, Mass. The presentation will be archived for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company
based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a
novel cancer product, and has a robust clinical development pipeline of
product candidates. The Company's research, development and
commercialization activities are focused in two therapeutic areas: oncology
and inflammation. By applying its knowledge of the human genome,
understanding of disease mechanisms and industrialized drug discovery
platform, Millennium is developing an exciting pipeline of innovative
product candidates. The Company's website is http://www.millennium.com.
Contact:
Kyle Kuvalanka
(617) 761-4734
SOURCE Millennium Pharmaceuticals, Inc.
 back to top
Related links:
http://www.millennium.com/
Photo Notes:http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO
AP Archive: http:
http://www.prnewswire.com/comp/114562.html /
CONTACT:
Kyle Kuvalanka, +1-617-761-4734, for
Millennium Pharmaceuticals, Inc.
|
